Results From the Phase 2 PEARL-I Study: Interferon-Free Regimens of ABT-450/r + ABT-267 With or Without Ribavirin in Patients With HCV Genotype 4 Infection

التفاصيل البيبلوغرافية
العنوان: Results From the Phase 2 PEARL-I Study: Interferon-Free Regimens of ABT-450/r + ABT-267 With or Without Ribavirin in Patients With HCV Genotype 4 Infection
المؤلفون: Tianli Wang, Christophe Hézode, Regis A. Vilchez, Stanislas Pol, Tami Pilot-Matias, Sandra S. Lovell, Tarek Hassanein, Patrick Marcellin, Tolga Baykal, Katarzyna Fleischer-Stępniewska
المصدر: American Journal of Gastroenterology. 109:S131
بيانات النشر: Ovid Technologies (Wolters Kluwer Health), 2014.
سنة النشر: 2014
مصطلحات موضوعية: Hepatology, business.industry, Ribavirin, Interferon free, Gastroenterology, engineering.material, Virology, chemistry.chemical_compound, chemistry, Genotype, engineering, Medicine, In patient, business, Pearl
تدمد: 0002-9270
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::64aeb44830ab20dacfc173af04908cfdTest
https://doi.org/10.14309/00000434-201410002-00438Test
رقم الانضمام: edsair.doi...........64aeb44830ab20dacfc173af04908cfd
قاعدة البيانات: OpenAIRE